Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 22:11:31.
doi: 10.1186/1745-6215-11-31.

Reasons for participating in randomised controlled trials: conditional altruism and considerations for self

Affiliations

Reasons for participating in randomised controlled trials: conditional altruism and considerations for self

Sharon K McCann et al. Trials. .

Abstract

Background: Randomised controlled trials of healthcare interventions depend on the participation of volunteers who might not derive any personal health benefit from their participation. The idea that altruistic-type motives are important for trial participation is understandably widespread, but recent studies suggest considerations of personal benefit can influence participation decisions in various ways.

Methods: Non-participant observation of recruitment consultations (n = 25) and in-depth interviews with people invited to participate in the UK REFLUX trial (n = 13).

Results: Willingness to help others and to contribute towards furthering medical knowledge featured strongly among the reasons people gave for being interested in participating in the trial. But decisions to attend recruitment appointments and take part were not based solely on consideration of others. Rather, they were presented as conditional on individuals additionally perceiving some benefit (and no significant disadvantage) for themselves. Potential for personal benefit or disadvantage could be seen in both the interventions being evaluated and trial processes.

Conclusions: The term 'conditional altruism' concisely describes the willingness to help others that may initially incline people to participate in a trial, but that is unlikely to lead to trial participation in practice unless people also recognise that participation will benefit them personally. Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation.

Trial registration: ISRCTN15517081.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic overview of considerations reported to influence participation in the REFLUX trial.

Similar articles

Cited by

References

    1. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. "Barriers to participation in randomised controlled trials: A systematic review". Journal of clinical epidemiology. 1999;52:1143–1156. doi: 10.1016/S0895-4356(99)00141-9. - DOI - PubMed
    1. Jenkins VA, Fallowfield LJ, Souhami A, Sawtell M. How do doctors explain randomised clinical trials to their patients?". European Journal of Cancer. 1999;35:1187–1193. doi: 10.1016/S0959-8049(99)00116-1. - DOI - PubMed
    1. Hussain-Gambles M. "South Asian patients' views and experiences of clinical trial participation". Family Practice. 2004;21:636–642. doi: 10.1093/fampra/cmh611. - DOI - PubMed
    1. McDonald AE, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA. "What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies". Trials. 2006;7:9. doi: 10.1186/1745-6215-7-9. (7 April). - DOI - PMC - PubMed
    1. Featherstone K, Donovan JL. "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial". Social Science & Medicine. 2002;55:709–719. - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources